Latest / Decera Clinical Education Oncology Podcast
A Cancer Conversation: Optimizing the Care of Patients With CLL Through a Deeper Understanding of BTK Inhibitor Resistance
In this episode, listen to Matthew S. Davids, MD, MMSc, and Lindsey Roeker, MD, discuss BTK inhibitor resistance and how it shapes treatment choices for patients with CLL, including:
Contemporary treatment paradigms for patients with CLL
Safety and efficacy of current regimens
Molecular testing, including when and how to test for BTK inhibitor resistance
Considering BTK inhibitor resistance when sequencing therapy
Program faculty:
Matthew S. Davids, MD, MMSc
Associate Professor of Medicine
Harvard Medical School
Leader, Lymphoma Program
Dana-Farber/Harvard Cancer Center
Director of…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.